October 20, 2023
Recent Advance Articles
The first biologic targeting IL-17A and IL-17F is now approved for adults with moderate to severe plaque psoriasis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.